Correction to: Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study.

Autor:	Garcia-Romero, Ruth1 (AUTHOR) ruthgarciaromero@yahoo.es, de Zabarte Fernandez, José Miguel Martinez2 (AUTHOR), Pujol-Muncunill, Gemma3 (AUTHOR), Donat-Aliaga, Ester4 (AUTHOR), Segarra-Cantón, Oscar5 (AUTHOR), Irastorza-Terradillos, Iñaki6 (AUTHOR), Medina-Benitez, Enrique7 (AUTHOR), Ruiz-Hernández, Carlos José8 (AUTHOR), Carrillo-Palau, Marta9 (AUTHOR), Ros-Arnal, Ignacio1 (AUTHOR), Rodriguez-Martínez, Alejandro10 (AUTHOR), Escartin-Madurga, Laura11 (AUTHOR), Gutiérrez-Junquera, Carolina12 (AUTHOR), Vicente-Santamaría, Saioa13 (AUTHOR), Rodriguez-Belvis, Marta Velasco14 (AUTHOR), Fernández-Fernández, Sonia15 (AUTHOR), Alberto-Alonso, José Ramón16 (AUTHOR), Montraveta, Montserrat17 (AUTHOR), Torres-Peral, Ricardo18 (AUTHOR), Navalon-Rubio, María19 (AUTHOR)
Zdroj:	European Journal of Pediatrics. Sep2021, Vol. 180 Issue 9, p3039-3040. 2p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu